Anti-viral drug Remdesivir would be made available directly to private hospitals to avoid overcrowding in places designated for its prescription based sale by state authorities to the kin of COVID-19 patients, the Tamil Nadu government said here on Sunday. Effective May 18, a facility would be made available to private hospitals to register their drug requirement in a portal and only their representatives should collect the medicine from sale depots. While information on the portal would soon be released, the hospitals must furnish information related to intended recipients, the oxygen dependent patients, the government said in an official release. The state-run Tamil Nadu Medical Services Corporation provided the drug to government hospitals.
The government stated that antiviral Remdesivir drug should only be administered for patients who are undergoing treatment with oxygen support. The drug has limited benefit for other patients.
COVID-19: Remdesivir to be supplied directly to private hospitals, says Tamil Nadu govt
Effective May 18, a facility would be made available to private hospitals to register their drug requirement in a portal and only their representatives should collect the medicine from sale depots
PTI | May 16, 2021 | Updated 19:00 IST
The state-run Tamil Nadu Medical Services Corporation provided the drug to government hospitals
Anti-viral drug Remdesivir would be made available directly to private hospitals to avoid overcrowding in places designated for its prescription based sale by state authorities to the kin of COVID-19 patients, the Tamil Nadu government said here on Sunday.
Effective May 18, a facility would be made available to private hospitals to register their drug requirement in a portal and only their representatives should collect the medicine from sale depots.
COVID-19: Remdesivir to be supplied directly to private hospitals, says Tamil Nadu govt origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.